Dr. Agarwal's Healthcare IPO Day 2: Check GMP, Subscription Status & Key Highlights

30 January 2025
3 min read
Dr. Agarwal's Healthcare IPO Day 2: Check GMP, Subscription Status & Key Highlights
whatsapp
facebook
twitter
linkedin
telegram
copyToClipboard

Dr. Agarwal's Healthcare launched its IPO on Jan 29, 2025 with a price band of ₹382-₹402/share. The IPO will be open from Jan 29, 2025 to Jan 31, 2025. Dr. Agarwal's Healthcare IPO will be listed on NSE & BSE with a tentative listing date scheduled for Wednesday, February 5, 2025. The allotment of shares will likely be finalised on Monday, February 3, 2025.

Dr. Agarwal's Healthcare IPO Day 2 Subscription Status

(January 30, 2025, Day 2)

Dr. Agarwal’s Healthcare IPO was subscribed 0.08 times as of 10:04 a.m., January 30, 2025 as per NSE data. The retail investor category led with a subscription of 0.13 times, while Non-Institutional Investors (NII) saw a subscription of 0.06 times. The lowest participation was from Qualified Institutional Buyers (QIBs), who have bid for just 18,375 shares against the 1,45,19,200 shares reserved for this category. Meanwhile, the quota reserved for employees and shareholders has been subscribed 0.09 and 0.15 times, respectively.

Dr. Agarwal’s Healthcare IPO  Day 1 Subscription Status

(January 29, 2025, 11:09:52 AM, Day 1)

By January 29, 2025, Dr. Agarwal’s Healthcare IPO was subscribed 0.02 times as of 10:40 a.m. on Wednesday, Jan 29, 2025, as per the BSE data. The retail investor category led with a subscription of 0.03 times, while Qualified Institutional Buyers (QIB) subscribed 0 times, and Non-Institutional Investors (NII) saw a subscription of 0.05 times. 

Also Read : Dr. Agarwal’s Healthcare IPO  Day 1 Subscription Status

Dr. Agarwal’s Healthcare IPO Details

Dr. Agarwal’s Healthcare IPO offering includes a fresh issue of shares worth ₹300 crore and an offer for sale (OFS) of existing shares worth ₹2,727.26 crore. The price band is set at ₹382 to ₹402 per share. The shares are expected to be listed on the BSE and NSE on February 5, 2025. The IPO is managed by Kotak Mahindra Capital, Morgan Stanley India, Jefferies India, and Motilal Oswal Investment Advisors, with Kfin Technologies as the registrar. The basis of allotment will be finalized on February 3, 2025, followed by the initiation of refunds on February 4, 2025. 

Utilisation of Proceeds

The company proposes to utilise the net proceeds from the fresh issue towards funding of the following objects:

  1. Repayment/prepayment, in part or full, of certain of our borrowings and
  2. General corporate purposes and unidentified inorganic acquisition

GMP Details

According to Business Standard, as of January 30, 2025, at 10:20 AM, the latest GMP for Dr Agarwal’s Healthcare IPO stands at ₹5, indicating a 1.24% premium over the upper end of the issue price. As per the latest GMP trends, the estimated listing price is projected to be Rs 407.

Dr. Agarwal’s Healthcare Business Overview

Dr. Agarwal's Health Care is a healthcare provider focused on advanced eye care services, operating under the brand Dr. Agarwal’s Eye Institute. The company offers a range of services, including routine eye check-ups, cataract surgeries, LASIK procedures, retina treatments, and corneal transplants. As of September 2024, the company has a network of 209 facilities, including 16 in Africa and 193 in India, making it the largest among its peers. The company also emphasizes research and development in ophthalmology. In FY24, Dr Agarwal's Healthcare served 2.13 million patients and performed over 220,000 surgeries.

Disclaimer: The GMP (Grey Market Premium) price is unauthenticated market-related news and has no discernible basis. The same quoted above is as per news that appeared in the media report and is for information purposes only. The investor shall do their own study/research before using the same for taking any decision to invest. We neither engage in, trade or deal in the grey market nor do we recommend or endorse trading in the grey market.

Do you like this edition?
ⓒ 2016-2025 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.7.6
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ